We are live on ! Find out more
TRCT

Tower Research Capital (TRC) Portfolio holdings

AUM $3.85B
1-Year Est. Return 32.11%
This Fund
S&P 500
This Quarter Est. Return
-1.34%
1 Year Est. Return
+32.11%
3 Year Est. Return
+93.86%
5 Year Est. Return
+112.79%
10 Year Est. Return
+380.9%
AUM
$1.17B
AUM Growth
+$393M
Cap. Flow
+$459M
Cap. Flow %
39.32%
Top 10 Hldgs %
24.34%
Holding
4,355
New
842
Increased
1,505
Reduced
871
Closed
1,089

Sector Composition

Rank Sector Weight
1 Financials 6.75%
2 Industrials 5.87%
3 Consumer Discretionary 5.39%
4 Technology 4.75%
5 Healthcare 3.78%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
KOP icon
2551
Koppers
KOP
$956M
$8K ﹤0.01%
+200
New +$8.8K
LAKE icon
2552
Lakeland Industries
LAKE
$119M
$8K ﹤0.01%
610
-2,296
-79% -$31.1K
MDB icon
2553
MongoDB
MDB
$33.5B
$8K ﹤0.01%
189
-970
-84% -$31.4K
MOG.A icon
2554
Moog Inc Class A
MOG.A
$13B
$8K ﹤0.01%
100
-1,001
-91% -$86.4K
NAK
2555
Northern Dynasty Minerals
NAK
$953M
$8K ﹤0.01%
8,300
-17,700
-68% -$21.2K
NHC icon
2556
National Healthcare
NHC
$3.46B
$8K ﹤0.01%
135
-268
-67% -$16.4K
NVRI icon
2557
Enviri
NVRI
$615M
$8K ﹤0.01%
393
-9,437
-96% -$181K
P
2558
Everpure Inc
P
$32.6B
$8K ﹤0.01%
400
+187
+88% +$3.67K
QCOM icon
2559
Qualcomm
QCOM
$170B
$8K ﹤0.01%
144
-24,718
-99% -$1.58M
RELL icon
2560
Richardson Electronics
RELL
$292M
$8K ﹤0.01%
935
-875
-48% -$6.87K
RGCO icon
2561
RGC Resources
RGCO
$225M
$8K ﹤0.01%
300
-977
-77% -$24.6K
RYTM icon
2562
Rhythm Pharmaceuticals
RYTM
$7.95B
$8K ﹤0.01%
+392
New +$10.4K
SEM
2563
DELISTED
Select Medical
SEM
$8K ﹤0.01%
854
-32,159
-97% -$306K
SOR
2564
Source Capital
SOR
$383M
$8K ﹤0.01%
+200
New +$8.26K
STRT icon
2565
STRATTEC Security
STRT
$349M
$8K ﹤0.01%
203
+30
+17% +$1.16K
TZOO icon
2566
Travelzoo
TZOO
$73.9M
$8K ﹤0.01%
1,122
-1,445
-56% -$9.8K
UIS icon
2567
Unisys
UIS
$211M
$8K ﹤0.01%
699
-3,339
-83% -$33.6K
IDEX
2568
DELISTED
Ideanomics, Inc. Common Stock
IDEX
$8K ﹤0.01%
31
-11
-26% -$4.09K
AGRX
2569
DELISTED
Agile Therapeutics
AGRX
$8K ﹤0.01%
+2
New +$13.2K
SRRA
2570
DELISTED
Sierra Oncology, Inc. Common Stock
SRRA
$8K ﹤0.01%
97
+63
+185% +$7.14K
ENIA
2571
DELISTED
Enel Amricas S.A. American Depositary Shares (Each representing 50 shares of Common Stock)
ENIA
$8K ﹤0.01%
667
-24,128
-97% -$276K
ARA
2572
DELISTED
American Renal Associates Holdings, Inc
ARA
$8K ﹤0.01%
446
+37
+9% +$730
TIVO
2573
DELISTED
Tivo Inc
TIVO
$8K ﹤0.01%
570
-1,268
-69% -$18.1K
MPVD
2574
DELISTED
Mountain Province Diamonds Inc.
MPVD
$8K ﹤0.01%
3,193
-3,655
-53% -$9.81K
MDCO
2575
DELISTED
Medicines Co
MDCO
$8K ﹤0.01%
236
+34
+17% +$1.06K

Similar funds

Tower Research Capital (TRC)'s Q1 2018 Portfolio in Review

As of Q1 2018, Tower Research Capital (TRC) held 4,355 positions worth $1.17B, up 51% from $775M the previous quarter. Its ten largest holdings account for 24% of the portfolio.

Tower Research Capital (TRC) deployed $459M of net new capital in Q1 2018, opening 842 new positions and adding to 1,505 existing holdings. Its largest new stake was iShares MSCI EAFE ETF: 717,758 shares worth $50M.

By sector, the portfolio is most concentrated in Financials at 6.7% of assets, down from 11% a quarter earlier, followed by Industrials and Consumer Discretionary.

On the sell side, the largest reduction was State Street SPDR S&P 500 ETF Trust, an estimated $21M trimmed.

  • Tower Research Capital (TRC)'s largest Q1 2018 buy was iShares MSCI EAFE ETF: 717,758 shares worth $50M.
  • Tower Research Capital (TRC) added most to iShares MSCI Emerging Markets ETF in Q1 2018, an estimated $69.7M increase.
  • Tower Research Capital (TRC)'s biggest Q1 2018 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $21M.
  • Tower Research Capital (TRC) fully exited Berkshire Hathaway Class B in Q1 2018, selling an estimated $7.94M.
  • Tower Research Capital (TRC)'s ten largest holdings make up 24% of its $1.17B portfolio in Q1 2018.
  • Tower Research Capital (TRC) opened 842 new positions and closed 1,089 in Q1 2018.
  • Tower Research Capital (TRC)'s portfolio value rose 51% quarter-over-quarter to $1.17B.

Based on Tower Research Capital (TRC)'s 13F filing for Q1 2018, filed 15 May 2018.